Priorix-Tetra Powder and Diluent for Solution for Injection

Manufacturer
GLAXOSMITHKLINE BIOLOGICALS S.A
 
Contents
Per 0.5 mL Live attenuated Schwarz measles virus strain not <10³ CCID₅₀, RIT 4385 mumps virus strain (derived from Jeryl Lynn strain) not <10^4.4 CCID₅₀, rubella virus strain (Wistar RA 27/3) not <10³ CCID₅₀ & OKA varicella virus strain not <10^3.3 PFU
 
Indication
Immunisation against measles, mumps, rubella and varicella.
 
Instruction
The doctor or nurse will give PRIORIX-TETRA as an injection. PRIORIX-TETRA is generally given as a single 0.5mL dose. The vaccine comes as a powder which is mixed with sterile water before use. PRIORIX-TETRA is injected under the skin (subcutaneously) or into the muscle (intramuscularly). PRIORIX-TETRA is generally injected into the upper leg in infants under 12 months of age. In children over 12 months of age the injection may be given in the upper arm.
 
Drug interaction
Tell your doctor if your child is taking or has recently taken any other medicines or have recently received any other vaccine. The use of salicylates (a substance present in many medicines used to lower fever and relieve pain) should be avoided for 6 weeks following vaccination with Priorix-Tetra. Priorix-Tetra can be given at the same time as diphtheria, tetanus, acellular pertussis (whooping cough), Haemophilus influenzae type b, inactivated polio (infantile paralysis) and hepatitis B vaccines. The injections should be given at separate injection sites.